Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Laryngoscope ; 125(4): 852-5, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25124395

RESUMEN

Acute supraglottitis is a medical emergency as it can rapidly lead to airway compromise. With routine pediatric immunization for Hemophilus influenzae serotype b, supraglottitis is now more prevalent in adults, with a shift in the causative organisms and a change in the natural history of this disease. Here, we present a case of supraglottitis due to group B streptococcus that occurred in an adult with previously undetected immunoglobulin 4 (IgG4) and complement protein C2 deficiency.


Asunto(s)
Huésped Inmunocomprometido/inmunología , Infecciones Estreptocócicas/diagnóstico , Streptococcus agalactiae/aislamiento & purificación , Supraglotitis/inmunología , Supraglotitis/microbiología , Corticoesteroides/uso terapéutico , Adulto , Antibacterianos/uso terapéutico , Complemento C2/deficiencia , Complemento C2/inmunología , Servicio de Urgencia en Hospital , Estudios de Seguimiento , Humanos , Deficiencia de IgG/inmunología , Masculino , Enfermedades Raras , Medición de Riesgo , Índice de Severidad de la Enfermedad , Infecciones Estreptocócicas/tratamiento farmacológico , Supraglotitis/diagnóstico , Supraglotitis/tratamiento farmacológico , Resultado del Tratamiento
3.
Anticancer Res ; 24(1): 339-43, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15015618

RESUMEN

BACKGROUND: The lung is the most common site for primary cancer worldwide as well as being a common site of metastases for various malignancies. Percutaneous radiofrequency ablation (RFA) is rapidly evolving as a new minimally invasive tool for the treatment of pulmonary tumors. PATIENTS AND METHODS: A questionnaire was sent by e-mail to 14 centres around the world, which we knew or thought were performing percutaneous pulmonary RFA, to retrospectively survey their experience in this field including the number of ablations done to date, indications, method, peri- and postprocedural complications. RESULTS: Seven centers reported 493 percutaneous procedures in lung tumors. Two deaths have been reported. Complications were subdivided into major and minor complications. Pneumothorax occurred in up to 30% of interventions with less than 10% requiring intercostal drainage. Pleural effusion requiring aspiration occurred in less than 10% of cases. CONCLUSION: With almost 500 procedures done to date, percutaneous pulmonary RFA appears to be a safe, minimally invasive tool for local pulmonary tumor control with negligible mortality, little morbidity, short hospital stay and gain in quality of life.


Asunto(s)
Ablación por Catéter/métodos , Neoplasias Pulmonares/cirugía , Ablación por Catéter/efectos adversos , Ablación por Catéter/estadística & datos numéricos , Encuestas de Atención de la Salud , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...